⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RDY News
Dr. Reddy's Laboratories Limited American Depositary Shares
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dr. Reddy's Laboratories Limited (RDY) And Encourages Stockholders to Reach Out
accessnewswire.com
RDY
RDY Investor Alert: Levi & Korsinsky Investigates Dr. Reddy's Laboratories Limited (RDY) For Potential Securities Fraud
accessnewswire.com
RDY
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy’s Laboratories (RDY)
globenewswire.com
RDY
RDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy’s Laboratories (RDY)
businesswire.com
RDY
Dr. Reddy's Laboratories Limited Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Dr. Reddy's Laboratories Limited (RDY)
accessnewswire.com
RDY
RDY SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Dr. Reddy's Laboratories
prnewswire.com
RDY
Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)
prnewswire.com
RDY
Dr. Reddy's Laboratories Limited (RDY) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
RDY
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
businesswire.com
RDY
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif ®, in the United States
businesswire.com
RDY